First Time Loading...
S

Shanghai Junshi Biosciences Co Ltd
SSE:688180

Watchlist Manager
Shanghai Junshi Biosciences Co Ltd
SSE:688180
Watchlist
Price: 30.14 CNY 7.84% Market Closed
Updated: Apr 30, 2024

Shanghai Junshi Biosciences Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Junshi Biosciences Co Ltd
Revenue Peer Comparison

Comparables:
6160
1801
603392
S
002252
300122

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Junshi Biosciences Co Ltd
SSE:688180
Revenue
¥1.5B
CAGR 3-Years
-2%
CAGR 5-Years
249%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Revenue
¥9.6B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Revenue
¥6.2B
CAGR 3-Years
17%
CAGR 5-Years
266%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Revenue
¥5.5B
CAGR 3-Years
33%
CAGR 5-Years
41%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Revenue
¥7.6B
CAGR 3-Years
41%
CAGR 5-Years
32%
CAGR 10-Years
27%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Revenue
¥49.7B
CAGR 3-Years
53%
CAGR 5-Years
65%
CAGR 10-Years
50%

See Also

What is Shanghai Junshi Biosciences Co Ltd's Revenue?
Revenue
1.5B CNY

Based on the financial report for Dec 31, 2023, Shanghai Junshi Biosciences Co Ltd's Revenue amounts to 1.5B CNY.

What is Shanghai Junshi Biosciences Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
249%

Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for Shanghai Junshi Biosciences Co Ltd have been -2% over the past three years , 249% over the past five years .